Kang, Un Jung

DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson’s disease

Hong, Z., Shi, M., Chung, K. A., Quinn, J. F., Peskind, E. R., Galasko, D., Jankovic, J., Zabetian, C. P., Leverenz, J. B., Baird, G., et al. (2010) · Brain

Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders

Cited by 615

SMPD1 mutations, activity, and α‐synuclein accumulation in Parkinson's disease

Alcalay, R. N., Mallett, V., Vanderperre, B., Tavassoly, O., Dauvilliers, Y., Wu, R. Y. J., Ruskey, J. A., Leblond, C. S., Ambalavanan, A., Laurent, S. B., et al. (2019) · Movement Disorders

Parkinson's Disease Mechanisms and TreatmentsLysosomal Storage Disorders Research

Cited by 110

Dopamine-dependent motor learning: insight into levodopa's long-duration response

Beeler, J. A., Cao, Z. F. H., Kheirbek, M. A., Ding, Y., Koranda, J., Murakami, M., Kang, U. J., & Zhuang, X. (2010) · Annals of Neurology

Parkinson's Disease Mechanisms and TreatmentsMotor Control and Adaptation

Cited by 104

Brain-derived neurotrophic factor-transduced fibroblasts: Production of BDNF and effects of grafting to the adult rat brain

Lucidi‐Phillipi, C. A., Gage, F. H., Shults, C. W., Jones, K. R., Reichardt, L. F., & Kang, U. J. (1995) · Journal of Comparative Neurology

Nerve injury and regenerationParkinson's Disease Mechanisms and Treatments

Cited by 72

Defining the molecular identity and morphology of glia limitans superficialis astrocytes in mouse and human

Hasel, P., Cooper, M. L., Marchildon, A. E., Rufen-Blanchette, U. A., Kim, R. D., Ma, T. C., Kang, U. J., Chao, M. V., & Liddelow, S. A. (2023) · Cell Reports

Neuroinflammation and Neurodegeneration MechanismsBarrier Structure and Function Studies

Cited by 47